SME · BSE SMEListed

ACCRETION NUTRAVEDA LIMITED IPO: dates, price band, lot size, objects of the issue

Get analyst updates on this IPO

Analyst updates come by email.

What changed since listing, from SEBI-registered research analysts.

By continuing you agree to the Terms and Privacy policy

Updated Tue 17 Nov 2026, 10:51 am IST · Source: Prospectus dated Mon 2 Feb 2026

Bid dates
Wed 28 Jan 2026 to Fri 30 Jan 2026
Listing date
Wed 4 Feb 2026
Issue price
₹129 per share

Listed on BSE on Wed 4 Feb 2026.

Listing price ₹191

Opening price on BSE on the listing day (BSE daily price file for Wed 4 Feb 2026)

This page is now frozen. Facts stay as filed; the quote is on the exchange.

Key facts

Issue price
₹129 per share
Prospectus dated Mon 2 Feb 2026, page 2
Lot size
Not stated in the prospectus
Prospectus dated Mon 2 Feb 2026
Lot amount at the upper band
Not stated in the prospectus
Prospectus dated Mon 2 Feb 2026
Issue size at the upper band
₹24.77 crore
Fresh issue
₹24.77 crore
Prospectus dated Mon 2 Feb 2026, page 1
Offer for sale
None
Prospectus dated Mon 2 Feb 2026, page 1
Bid dates
Wed 28 Jan 2026 to Fri 30 Jan 2026
Prospectus dated Mon 2 Feb 2026, page 1
Listing date
Wed 4 Feb 2026
BSE daily price file for Wed 4 Feb 2026
Anchor lock-in ends
Not stated in the prospectus
Prospectus dated Mon 2 Feb 2026
Risk factors
83
Prospectus dated Mon 2 Feb 2026, page 74

Timeline (IST)

  1. OpensWed 28 Jan 2026, 10:00 am IST confirmedProspectus dated Mon 2 Feb 2026, page 1
  2. ClosesFri 30 Jan 2026 confirmedProspectus dated Mon 2 Feb 2026, page 1
  3. UPI mandate cut-offNot stated in the prospectus Prospectus dated Mon 2 Feb 2026
  4. AllotmentMon 2 Feb 2026 by T+3 schedule
  5. Refund and unblockTue 3 Feb 2026 by T+3 schedule
  6. Shares to dematTue 3 Feb 2026 by T+3 schedule
  7. ListingWed 4 Feb 2026 confirmedBSE daily price file for Wed 4 Feb 2026

Objects of the issue

ObjectAmount
Purchase of Machineries for Automation in existing Manufacturing unit₹4.22 crore
Purchase of Machineries for New Manufacturing Setup₹8.03 crore
Funding working capital requirements of our company₹5.50 crore
General corporate purposes₹3.69 crore
Total₹21.44 crore

Prospectus dated Mon 2 Feb 2026, page 136

Company and promoters

As described in the prospectus

Accretion Nutraveda Limited, founded in 2021 in Ahmedabad, is a healthcare-focused Contract Development and Manufacturing Organization (CDMO).

Prospectus dated Mon 2 Feb 2026, page 30

Promoters

  • 6 individual promoters

Prospectus dated Mon 2 Feb 2026, page 30

Shareholding

HoldingBefore the issueAfter the issue
Promoters and promoter group100.00%73.48%

Basis: At the upper end of the price band

Prospectus dated Mon 2 Feb 2026, pages 31 to 126

Financials (restated)

ItemSeptember 30, 2025March 31, 2025March 31, 2024March 31, 2023
Revenue from operations₹14.06 crore₹16.00 crore₹5.01 crore₹2.90 crore
Profit after tax₹2.33 crore₹2.61 crore₹82.19 lakh₹28.06 lakh
Net worth₹8.27 crore₹5.35 crore₹1.08 crore₹26.31 lakh
Total borrowingsNot stated in the prospectusNot stated in the prospectusNot stated in the prospectusNot stated in the prospectus

Prospectus dated Mon 2 Feb 2026, page 80

SME issue facts

  • The face value of each Equity Share is ₹10/- and the Floor Price is ₹122/- per Equity Share and the Cap Price is ₹129/- (Prospectus dated Mon 2 Feb 2026, page 402)
  • that the minimum application size shall be two lots per application. Provided that the minimum application size shall be (Prospectus dated Mon 2 Feb 2026, page 404)
  • happen in the minimum contract size of 1000 Equity Shares and the same may be modified by the BSE SME from time (Prospectus dated Mon 2 Feb 2026, page 404)
  • done in multiples of 1000 Equity Shares and is subject to a minimum allotment of 2000 Equity Shares to the successful (Prospectus dated Mon 2 Feb 2026, page 404)
  • this Issue shall be 200 shareholders. In case the minimum number of prospective allottees is less than 200, no allotment (Prospectus dated Mon 2 Feb 2026, page 404)

Peer comparison (as in the Prospectus)

Name of the companyCurrent market price (₹)Face value (₹)EPS (Basic & Diluted)PERONW (%)NAV Per share (₹)Total income (₹ In lakhs)
Accretion Nutraveda Limited129/-104.7327.2756.50%16.741406.55
Walpar Nutritions Ltd.45.90101.063.306.24%17.052879.72
Influx Healthtech Limited226.00104.8146.9911.10%38.986685.92

Reproduced from the Prospectus dated Mon 2 Feb 2026, pages 160 to 161; InsightPier adds no figures

Risk factors

83 total
  1. Equipment failure, accidents or natural disasters at the single manufacturing facility could disrupt production (offer document page 39)
  2. Discrepancies and delayed filings in statutory forms with the Registrar of Companies could lead to penalties (offer document page 39)
  3. A few customers account for most sales, so losing one could hurt revenue (offer document page 41)
  4. Most revenue comes from Gujarat, concentrating geographic risk (offer document page 42)
  5. Orders for the machinery funded by the issue are not yet placed, so delays or cost increases are possible (offer document page 43)

All 83 risk factors, pages 38 to 74

Offer document

Allotment and bids

Registrar to the issue: KFin Technologies Limited.

Allotment status was expected on the registrar's site from Mon 2 Feb 2026 and is not yet confirmed. Pick "ACCRETION NUTRAVEDA LIMITED" from the issue list there.

Subscription (final)

CategoryShares offeredShares bid forTimes subscribed
Overall––1.91×

ipocentral.in and ipowatch.in, as of Tue 17 Nov 2026

Research

Research reports on IPOs from SEBI-registered research analysts, published on InsightPier.

Research reports on IPOs from SEBI-registered research analysts